Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.
about
Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioningThe outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionRole of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignanciesNon-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaTyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adultsCellular therapies in acute lymphoblastic leukemiaRole of reduced intensity transplant in adult patients with acute lymphoblastic leukemia: If and when?Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia.The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.Philadelphia-positive acute lymphoblastic leukemia: current treatment optionsOptimal approach to treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: how to best use all the available tools.Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.Advances in adult acute lymphoblastic leukemia therapy.Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how.Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT.Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission.Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working pa
P2860
Q26795740-10CE6AE3-B639-47F5-8B96-774295222321Q34033852-7E09BB54-013A-4936-BCBC-32B58811D6C6Q34532041-1AF13F13-5AEC-451F-A50C-4D1067AB7240Q34568898-8C2AEDF8-8E79-46CA-A6CA-468A401360E2Q35143457-40582BD9-135D-4066-BBCF-7545B9969CBDQ35146312-0A87B12A-AADB-47FB-8B8F-81DDE264628BQ36461915-E76DA312-EA55-4CB1-A41B-2C7A8874A2D5Q36552098-42B04B84-1CB9-4163-9C4B-6C4C13FCA017Q37181212-118D6E3E-D567-4097-BEBE-6C7787D04013Q37632798-5D32ED9D-FDEF-4209-8941-29B2DC6F86DCQ37919867-D2D78D3F-A49D-492E-861F-F856B607B6F7Q37992837-4D0541EA-B9E2-47A0-B11D-CC61042AB18BQ38016343-DC1935AB-9121-4BA2-95EB-68800A1640D3Q38023947-9E89BDB1-A202-48A9-954A-4F7F196DADF5Q38079288-34A5A337-F9C2-494C-B10C-AF72AA975765Q38087853-A5B0E42C-0ED2-4A7A-B5E4-ACEC0389B3A6Q38087930-6A540A74-3A2F-4DD5-AF81-2CD285B007E0Q38226100-4B5C93FE-E8D8-4D17-9BFE-AF5EA0A9F022Q38488058-FB0A39E0-C6AF-4A86-A201-AD152D4AC386Q39459190-A2B2E436-69BF-4B0C-97D4-F068C3978221Q41009415-2B01901A-4374-421E-B989-0F7E08AE5F44Q42852351-8722F1FB-F090-42DC-9B3F-ECFE37AD626BQ44399798-4AA5DD30-9CF6-4C5A-8696-222A6D5A40DCQ49165760-3D6AC697-8EEB-43C0-8E1E-227E1645E382Q49370276-4AB69E8F-9136-405E-BA0B-2D44DD96C2CEQ51815713-CE3DF9A5-0789-450F-A9FE-9BE77232F7CDQ55073539-B209B7F5-806F-493C-A7D2-5F4944657200
P2860
Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@en
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@nl
type
label
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@en
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@nl
prefLabel
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@en
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P1476
Reduced-intensity conditioning ...... acute lymphoblastic leukemia.
@en
P2093
Anthony S Stein
David S Snyder
David Senitzer
Joycelynne M Palmer
Margaret R O'Donnell
Marilyn L Slovak
Neil M Kogut
Ni-Chun Tsai
Ricardo T Spielberger
Sandra H Thomas
P2860
P304
P356
10.1016/J.BBMT.2009.07.003
P577
2009-11-01T00:00:00Z